Enveric Biosciences, Inc. (ENVB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.26M | -1.78M | -2.07M | -1.89M | -2.39M | -1.31M | -927.07K | -2.89M | -2.6M | -1.75M | -2.74M | -4.47M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 5.63% | -36.09% | -123.82% | 34.58% | 7.96% | 25.1% | 66.17% | 35.31% | 49.42% | 49.42% | 39.78% | 2.6% |
| Net Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.18M | -3.15M | -2.08M | -1.88M | -2.46M | -3.44M | -2.82M | -6.36M |
| Depreciation & Amortization | 37.24K | 39.48K | 40.37K | 39.98K | 81.02K | 82.49K | 84.81K | 84.78K | 85.41K | 84.48K | 95.84K | 114.37K |
| Stock-Based Compensation | 88.67K | 240.23K | 186.98K | 206.26K | 193.85K | 471.68K | 369.61K | 369.61K | 351.49K | 364.73K | 372.86K | 879.74K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.36M | 0 |
| Other Non-Cash Items | 19.6K | 29.45K | -128.68K | 0 | -2.56K | 411.6K | 623 | -18.57K | -21.44K | 1.03M | 2.73M | 597.75K |
| Working Capital Changes | -768.88K | 100.14K | -299.95K | 382.8K | -478.92K | 877.34K | 701.91K | -1.45M | -556.89K | 205.84K | 243.63K | 298.27K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -417.39K | -117.88K | -284.68K | 289.98K | -301.28K | 462.28K | 0 | 0 | 202.4K | 0 | -112.71K | -111.31K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38 | 0 | 16.85K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.87K |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -53 | 0 | 0 |
| Cash from Financing | 2.5M | 2.69M | 2.99M | 449.1K | 4.45M | 463.45K | 517.69K | 34.43K | 6.66M | -186.08K | -105K | -1.05M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 2.5M | 2.69M | 2.99M | 449.1K | 4.45M | -1.32M | 2.32M | 51.68K | 2.31M | 0 | 0 | -1.05M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 1.08M | 0 | 0 | 0 | 0 | 0 | -1.05M |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 1.78M | -1.8M | -17.25K | 4.35M | -186.08K | -105K | 0 |
| Net Change in Cash | 231.28K | 919.9K | 907.78K | -1.44M | 2.05M | -870.66K | -390.87K | -2.85M | 4.07M | -1.98M | -2.81M | -5.48M |
| Free Cash Flow | -2.26M | -1.78M | -2.07M | -1.89M | -2.39M | -1.31M | -927.07K | -2.89M | -2.6M | -1.75M | -2.74M | -4.47M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 5.63% | -36.09% | -123.82% | 34.58% | 7.96% | 25.1% | 66.17% | 35.31% | 49.47% | 49.51% | 40.02% | 3.73% |
| FCF per Share | -1.49 | -1.68 | -6.62 | -8.74 | -15943.88 | -24.03 | -7.91 | -24.64 | -22.16 | -17.08 | -26.73 | -43.56 |
| FCF Conversion (FCF/Net Income) | 1.38x | 0.81x | 1.11x | 0.75x | 1.09x | 0.42x | 0.44x | 1.54x | 1.06x | 0.51x | 0.97x | 0.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | -24K | 0 | 0 | 24K | 2.91K | 6.59K | 0 |